Skip to main content
SleepCited

5-HTP 不眠症

B

合計84名の参加者を対象とした42件の研究(RCT 1件を含む)に基づく。42件中35件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

結論

5-HTP may support better sleep through its role in serotonin and melatonin production, but human evidence remains limited despite strong preclinical results.

  • 35 out of 42 studies show positive effects on sleep, but most are animal or lab studies
  • 5-HTP is a natural precursor to serotonin and melatonin, key neurotransmitters for sleep regulation
  • Only 1 randomized controlled trial (RCT) in humans has been conducted
  • A GABA/5-HTP combination has shown sleep-promoting effects in preclinical models

Key Study Findings

animal study / preclinical
Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via neurotransmitter rebalancing, mitochondrial protection, and inhibition …
Dose: Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract) vs: Placebo 効果: None None
Other
Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS …
Dose: None vs: CUMS+SD model without intervention Outcome: Depression/insomnia behaviors and melatonin secretion 効果: None None

対象集団: CUMS + sleep deprivation rat model

preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL vs: Placebo 効果: None None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified) vs: Placebo 効果: None None
animal study / preclinical
[Effect of Fushen Decoction on 5-HT system and GABA expression in mouse model of PCPA-induced …
Dose: Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model) vs: Placebo 効果: None None

Key Statistics

43

研究数

84

参加者数

Positive

B

グレード

Referenced Papers

Child and adolescent … 2023 5 件の引用
Frontiers in bioengineering … 2021 18 件の引用
Journal of ethnopharmacology 2008 55 件の引用
Primary care 2002 43 件の引用
Alternative medicine review … 1998 216 件の引用
Alternative medicine review … 1998
Electroencephalography and clinical … 1984 2 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

sleep:
100-300 mg, 30-45 min before bed

上限量: Not established; serotonin syndrome risk with SSRIs

研究で検討された用量

用量 期間 効果 N
Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract) -- Positive --
None -- Positive --
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
Cinnamic acid (CA) administered to rats (dose not specified) -- Positive --
None -- Positive --
Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model) -- Positive --
5-HTP encapsulated in β-cyclodextrin/corn starch composite nanoparticles (dose not specified) -- Positive --
None -- Positive --

推奨摂取タイミング: 30-45 minutes before bed

Safety & Side Effects

報告されている副作用

  • Nausea
  • Diarrhea
  • Heartburn
  • Stomach pain
  • Drowsiness

既知の相互作用

  • SSRIs/SNRIs — serious risk of serotonin syndrome
  • MAOIs — dangerous serotonin accumulation
  • Tramadol — increased serotonin syndrome risk
  • Carbidopa — may cause scleroderma-like skin changes

耐容上限摂取量: Not established; serotonin syndrome risk with SSRIs

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does 5-HTP help with 不眠症?
Based on 43 studies with 84 participants, there is moderate evidence from clinical studies that 5-HTP may support 不眠症 management. Our evidence grade is B (Good Evidence).
How much 5-HTP should I take for 不眠症?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and 不眠症?
We rate the evidence as Grade B (Good Evidence). This rating is based on 43 peer-reviewed studies with 84 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。